Professor Martin Widschwendter, is Director of the Daffodil Centre at Cancer Council NSW and an internationally recognised leader in women’s cancer prevention and translational epigenetics. His research focuses on using molecular, behavioural and environmental information to better understand individual cancer risk and enable earlier, more personalised prevention and detection. Professor Widschwendter’s work raises an important question for the future of healthcare: can we move from treating cancer earlier to predicting and preventing it earlier? In this interview, Professor Widschwendter discusses how advances in risk prediction and molecular science could transform cancer prevention, the potential of personalised approaches, and the challenges of ensuring that new prevention strategies benefit diverse and underserved communities. He also explains the potential of the WID®-easy test, a non-invasive approach designed to help identify women at higher risk of endometrial cancer and reduce unnecessary invasive investigations.
